Goldman Sachs’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07M Hold
385,010
﹤0.01% 3913
2025
Q4
$4.03M Hold
385,010
﹤0.01% 3943
2025
Q3
$3.98M Hold
385,010
﹤0.01% 3860
2025
Q2
$3.95M Hold
385,010
﹤0.01% 3628
2025
Q1
$3.88M Buy
+385,010
New +$3.87M ﹤0.01% 3599

Other funds holding TDAC

Goldman Sachs's TDAC Position: Q1 2026 in Review

Goldman Sachs held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 385,010 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Goldman Sachs first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Goldman Sachs held 385,010 shares of Translational Development Acquisition Corp worth $4.07M as of Q1 2026.
  • Goldman Sachs left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3913 holding.
  • Goldman Sachs first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.